Tuesday, April 28, 2026
28.7
C
Bengaluru
Hot topics
Philippe Gautron Takes on Role as Senior Vice President & Business Head – APAC at Glenmark Pharmaceuticals
Ho Chi Minh City, Vietnam, March 2026 — Glenmark...
Unmasking the Ethics of PCD Pharma Cos and the Incentives of Luxury Cars
🎁 The Diwali Dazzle: A Gilded Distraction?
In October 2025,...
Cipla–Pfizer Deal: How “Ordinary” Brands Are Fueling an Extraordinary Power Shift in Indian Pharma
What’s really happening in the Cipla–Pfizer tie‑up
At first glance,...
Covid-19 Impact on Indian Pharma Revenues, Field Force, Doctors – Sunil Attavar, CMD Group Pharma
This is the third and final part of MedicinMan...
An Invitation from the Editor
FFE and BrandStorm 2016 Agenda inside. Articles by Raja Reddy, K. Hariram, Amit Jain, and Vivek Hattangadi.
Why Private Equity is the New Kingmaker in Pharma & MedTech
The PE Playbook: Why Private Equity is the New...
Tez Health and the New Race to Bring Healthcare Home
Tez Health and the New Race to Bring Healthcare...
Is Pharma M&A Slowing Down Amidst Geopolitical Friction?
The pharmaceutical industry stands at a critical juncture in...
Will the GLP Battle Now Shift from Injectable to Oral?
In India’s million-strong retail pharmacy universe, oral weight-loss pills...
The Semaglutide Paradox: Anatomy of a High-Stakes Commodity Trap
The Semaglutide Shift: From Blockbuster to Commodity
Why the $50...
Why Private Equity is the New Kingmaker in Pharma & MedTech
The PE Playbook: Why Private Equity is the New...
Tez Health and the New Race to Bring Healthcare Home
Tez Health and the New Race to Bring Healthcare...
Is Pharma M&A Slowing Down Amidst Geopolitical Friction?
The pharmaceutical industry stands at a critical juncture in...
Will the GLP Battle Now Shift from Injectable to Oral?
In India’s million-strong retail pharmacy universe, oral weight-loss pills...
The Semaglutide Paradox: Anatomy of a High-Stakes Commodity Trap
The Semaglutide Shift: From Blockbuster to Commodity
Why the $50...
Why Private Equity is the New Kingmaker in Pharma & MedTech
The PE Playbook: Why Private Equity is the New...
Tez Health and the New Race to Bring Healthcare Home
Tez Health and the New Race to Bring Healthcare...
Is Pharma M&A Slowing Down Amidst Geopolitical Friction?
The pharmaceutical industry stands at a critical juncture in...
Will the GLP Battle Now Shift from Injectable to Oral?
In India’s million-strong retail pharmacy universe, oral weight-loss pills...
The Semaglutide Paradox: Anatomy of a High-Stakes Commodity Trap
The Semaglutide Shift: From Blockbuster to Commodity
Why the $50...
Why Private Equity is the New Kingmaker in Pharma & MedTech
The PE Playbook: Why Private Equity is the New...
Tez Health and the New Race to Bring Healthcare Home
Tez Health and the New Race to Bring Healthcare...
Is Pharma M&A Slowing Down Amidst Geopolitical Friction?
The pharmaceutical industry stands at a critical juncture in...
Will the GLP Battle Now Shift from Injectable to Oral?
In India’s million-strong retail pharmacy universe, oral weight-loss pills...
The Semaglutide Paradox: Anatomy of a High-Stakes Commodity Trap
The Semaglutide Shift: From Blockbuster to Commodity
Why the $50...
Hot topics
Covid-19 Impact on Indian Pharma Revenues, Field Force, Doctors – Sunil Attavar, CMD Group Pharma
This is the third and final part of MedicinMan...
Cipla’s Leadership Transition from Umang Vohra to Achin Gupta: Succession Planning in Action
By Anup Soans | MedicinMan
Cipla Limited has announced a...
Indian Pharma November Sales: What Do They Say?
IQVIA's Market Feedback Report (MFR) and PharmaTrac's Acquaint report...
Indian Pharma October 2025 Sales Data
1. Overall Market Growth & Trends (IPM Key Highlights):
Robust...
Novo Nordisk to Acquire Akero Therapeutics for $4.7 Billion
Novo Nordisk has announced plans to acquire Akero Therapeutics...
Why Private Equity is the New Kingmaker in Pharma & MedTech
The PE Playbook: Why Private Equity is the New...
Tez Health and the New Race to Bring Healthcare Home
Tez Health and the New Race to Bring Healthcare...
Is Pharma M&A Slowing Down Amidst Geopolitical Friction?
The pharmaceutical industry stands at a critical juncture in...
Will the GLP Battle Now Shift from Injectable to Oral?
In India’s million-strong retail pharmacy universe, oral weight-loss pills...
The Semaglutide Paradox: Anatomy of a High-Stakes Commodity Trap
The Semaglutide Shift: From Blockbuster to Commodity
Why the $50...
Why Private Equity is the New Kingmaker in Pharma & MedTech
The PE Playbook: Why Private Equity is the New...
Tez Health and the New Race to Bring Healthcare Home
Tez Health and the New Race to Bring Healthcare...
Is Pharma M&A Slowing Down Amidst Geopolitical Friction?
The pharmaceutical industry stands at a critical juncture in...
Will the GLP Battle Now Shift from Injectable to Oral?
In India’s million-strong retail pharmacy universe, oral weight-loss pills...
The Semaglutide Paradox: Anatomy of a High-Stakes Commodity Trap
The Semaglutide Shift: From Blockbuster to Commodity
Why the $50...
Why Private Equity is the New Kingmaker in Pharma & MedTech
The PE Playbook: Why Private Equity is the New...
Tez Health and the New Race to Bring Healthcare Home
Tez Health and the New Race to Bring Healthcare...
Is Pharma M&A Slowing Down Amidst Geopolitical Friction?
The pharmaceutical industry stands at a critical juncture in...
Will the GLP Battle Now Shift from Injectable to Oral?
In India’s million-strong retail pharmacy universe, oral weight-loss pills...
The Semaglutide Paradox: Anatomy of a High-Stakes Commodity Trap
The Semaglutide Shift: From Blockbuster to Commodity
Why the $50...
Why Private Equity is the New Kingmaker in Pharma & MedTech
The PE Playbook: Why Private Equity is the New...
Tez Health and the New Race to Bring Healthcare Home
Tez Health and the New Race to Bring Healthcare...
Is Pharma M&A Slowing Down Amidst Geopolitical Friction?
The pharmaceutical industry stands at a critical juncture in...
Will the GLP Battle Now Shift from Injectable to Oral?
In India’s million-strong retail pharmacy universe, oral weight-loss pills...
The Semaglutide Paradox: Anatomy of a High-Stakes Commodity Trap
The Semaglutide Shift: From Blockbuster to Commodity
Why the $50...
MedicinMan was launched in 2011 as India’s 1st Magazine dedicated to the cause of Field Force Excellence in Pharma and Devices.
Read More
Headlines
Why Private Equity is the New Kingmaker in Pharma & MedTech
The PE Playbook: Why Private Equity is the New...
Tez Health and the New Race to Bring Healthcare Home
Tez Health and the New Race to Bring Healthcare...
Is Pharma M&A Slowing Down Amidst Geopolitical Friction?
The pharmaceutical industry stands at a critical juncture in...
Will the GLP Battle Now Shift from Injectable to Oral?
In India’s million-strong retail pharmacy universe, oral weight-loss pills...
Newsletter
Get important news delivered directly to your inbox and stay connected!